Tag: cara therapeutics

January 16, 2020

New Cannabis ETF Makes European Debut

Purpose Investments participated in the debut of the Medical Cannabis & Wellness UCITS ETF, which offers cannabis exposure to Europeans.
December 3, 2019

Cara Therapeutics Tumbles on Phase 2 Oral KORSUVA Results

Cara Therapeutics said Oral KORSUVA met its primary endpoint in the Phase 2 trial, but didn't meet its secondary endpoints.
December 3, 2019

Cara Therapeutics Announces Results from Phase 2 Trial of KORSUVA

The company released positive topline results from its Phase 2 dose-ranging trial of Oral KORSUVA to treat pruritus in chronic...
August 21, 2019

Cara Therapeutics and Enteris BioPharma Enter Commercial License Agreement

Cara Therapeutics (NASDAQ:CARA) has announced it has entered into a license agreement with Enteris BioPharma for oral formulation rights to...
August 13, 2019

Are US Marijuana Stocks a Good Buy?

The US has emerged as a cannabis powerhouse, but are US marijuana stocks a good buy for the average investor?
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 1, 2018

5 Top NASDAQ Biotech Stocks: Cardiome on Top

Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices.